Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Blood. 2012 Nov 15;120(20):4160-7. doi: 10.1182/blood-2012-07-443051. Epub 2012 Sep 18.
The 4Ts is a pretest clinical scoring system for heparin-induced thrombocytopenia (HIT). Although widely used in clinical practice, its predictive value for HIT in diverse settings and patient populations is unknown. We performed a systematic review and meta-analysis to estimate the predictive value of the 4Ts in patients with suspected HIT. We searched PubMed, Cochrane Database, and ISI Web of Science for studies that included patients with suspected HIT, who were evaluated by both the 4Ts and a reference standard against which the 4Ts could be compared. Quality of eligible studies was assessed by QUADAS-2 criteria. Thirteen studies, collectively involving 3068 patients, fulfilled eligibility criteria. A total of 1712 (55.8%) patients were classified by 4Ts score as having a low probability of HIT. The negative predictive value of a low probability 4Ts score was 0.998 (95% CI, 0.970-1.000) and remained high irrespective of the party responsible for scoring, the prevalence of HIT, or the composition of the study population. The positive predictive value of an intermediate and high probability 4Ts score was 0.14 (0.09-0.22) and 0.64 (0.40-0.82), respectively. A low probability 4Ts score appears to be a robust means of excluding HIT. Patients with intermediate and high probability scores require further evaluation.
4Ts 是肝素诱导的血小板减少症 (HIT) 的一种预测试临床评分系统。尽管在临床实践中广泛应用,但它在不同环境和患者人群中对 HIT 的预测价值尚不清楚。我们进行了一项系统评价和荟萃分析,以估计 4Ts 在疑似 HIT 患者中的预测价值。我们在 PubMed、Cochrane 数据库和 ISI Web of Science 中搜索了包含疑似 HIT 患者的研究,这些患者均通过 4Ts 和参考标准进行了评估,可将 4Ts 与之进行比较。合格研究的质量通过 QUADAS-2 标准进行评估。共有 13 项研究,共涉及 3068 名患者,符合入选标准。共有 1712 名(55.8%)患者根据 4Ts 评分被归类为 HIT 可能性低。低概率 4Ts 评分的阴性预测值为 0.998(95%CI,0.970-1.000),且无论评分负责人、HIT 患病率或研究人群构成如何,该值均保持较高水平。中高概率 4Ts 评分的阳性预测值分别为 0.14(0.09-0.22)和 0.64(0.40-0.82)。低概率 4Ts 评分似乎是排除 HIT 的可靠方法。中高概率评分的患者需要进一步评估。